Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies

From its first description by Thomas Hodgkin in 1832, Hodgkin's disease, now called Hodgkin's lymphoma, has continued to be a fascinating neoplasm even to this day. In this review, historical aspects, epidemiology, diagnosis, tumor biology, new observations related to host-microenvironment...

Full description

Saved in:
Bibliographic Details
Main Author: Diponkar Banerjee
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Advances in Hematology
Online Access:http://dx.doi.org/10.1155/2011/439456
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850236922918600704
author Diponkar Banerjee
author_facet Diponkar Banerjee
author_sort Diponkar Banerjee
collection DOAJ
description From its first description by Thomas Hodgkin in 1832, Hodgkin's disease, now called Hodgkin's lymphoma, has continued to be a fascinating neoplasm even to this day. In this review, historical aspects, epidemiology, diagnosis, tumor biology, new observations related to host-microenvironment interactions, gene copy number variation, and gene expression profiling in this complex neoplasm are described, with an exploration of chemoresistance mechanisms and potential novel therapies for refractory disease.
format Article
id doaj-art-1bff0a9fc18c4920b86f29a4b0ac1f7f
institution OA Journals
issn 1687-9104
1687-9112
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series Advances in Hematology
spelling doaj-art-1bff0a9fc18c4920b86f29a4b0ac1f7f2025-08-20T02:01:51ZengWileyAdvances in Hematology1687-91041687-91122011-01-01201110.1155/2011/439456439456Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic StrategiesDiponkar Banerjee0Centre for Translational and Applied Genomics (CTAG), Department of Pathology, British Columbia Cancer Agency (BCCA), 600 West 10th Avenue, Vancouver, British Columbia, V5Z 4E6, CanadaFrom its first description by Thomas Hodgkin in 1832, Hodgkin's disease, now called Hodgkin's lymphoma, has continued to be a fascinating neoplasm even to this day. In this review, historical aspects, epidemiology, diagnosis, tumor biology, new observations related to host-microenvironment interactions, gene copy number variation, and gene expression profiling in this complex neoplasm are described, with an exploration of chemoresistance mechanisms and potential novel therapies for refractory disease.http://dx.doi.org/10.1155/2011/439456
spellingShingle Diponkar Banerjee
Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies
Advances in Hematology
title Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies
title_full Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies
title_fullStr Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies
title_full_unstemmed Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies
title_short Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies
title_sort recent advances in the pathobiology of hodgkin s lymphoma potential impact on diagnostic predictive and therapeutic strategies
url http://dx.doi.org/10.1155/2011/439456
work_keys_str_mv AT diponkarbanerjee recentadvancesinthepathobiologyofhodgkinslymphomapotentialimpactondiagnosticpredictiveandtherapeuticstrategies